Aspiriant LLC
LLY icon

Aspiriant LLC’s Eli Lilly LLY Stock Holding History

Aspiriant LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.25M Buy
1,943
+30
+2% +$35.4K 0.06% 106
2026
Q2 		$2.29M Buy
1,913
+330
+21% +$337K 0.06% 106
2026
Q1 		$1.46M Buy
1,583
+681
+75% +$690K 0.04% 133
2025
Q4 		$969K Buy
902
+335
+59% +$320K 0.03% 160
2025
Q3 		$433K Sell
567
-64
-10% -$47.6K 0.01% 212
2025
Q2 		$492K Sell
631
-25
-4% -$19.4K 0.02% 200
2025
Q1 		$542K Buy
656
+17
+3% +$14.1K 0.02% 182
2024
Q4 		$493K Sell
639
-139
-18% -$115K 0.02% 190
2024
Q3 		$689K Sell
778
-3,135
-80% -$2.82M 0.03% 166
2024
Q2 		$3.54M Buy
3,913
+3,195
+445% +$2.56M 0.14% 66
2024
Q1 		$559K Buy
718
+9
+1% +$6.4K 0.02% 186
2023
Q4 		$414K Buy
709
+69
+11% +$40.3K 0.02% 206
2023
Q3 		$344K Sell
640
-59
-8% -$30.4K 0.02% 209
2023
Q2 		$328K Buy
699
+19
+3% +$7.97K 0.02% 211
2023
Q1 		$234K Sell
680
-27
-4% -$9.11K 0.01% 252
2022
Q4 		$259K Buy
+707
New +$251K 0.01% 232
2021
Q3 		– Sell
-1,009
Closed -$232K – 240
2021
Q2 		$232K Buy
+1,009
New +$203K 0.01% 219
2020
Q4 		– Sell
-1,435
Closed -$212K – 214
2020
Q3 		$212K Buy
+1,435
New +$222K 0.02% 206
2018
Q2 		– Sell
-3,137
Closed -$243K – 255
2018
Q1 		$243K Buy
+3,137
New +$253K 0.02% 213

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Weatherly Asset Management
Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

Aspiriant LLC's LLY Position: Q3 2026 in Review

Aspiriant LLC increased its Eli Lilly (LLY) stake by 1.6% in Q3 2026, buying an estimated $35.4K and bringing the position to 1,943 shares worth $2.25M. The position accounts for 0.06% of the portfolio, ranked #106.

Aspiriant LLC first reported a position in LLY in Q1 2018 and has held it in 19 quarters since. The position peaked at $3.54M in Q2 2024. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Aspiriant LLC held 1,943 shares of Eli Lilly worth $2.25M as of Q3 2026.
  • Aspiriant LLC bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
  • Eli Lilly made up 0.06% of Aspiriant LLC's portfolio in Q3 2026, its #106 holding.
  • Aspiriant LLC first reported a position in Eli Lilly in Q1 2018 and has held it in 19 quarters since.
  • Aspiriant LLC's Eli Lilly position peaked at $3.54M in Q2 2024.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.